💉 Diabetes Management
Development of automated insulin delivery systems simplifies diabetes management - Medical Device Network
📅 Tue, 25 Oct 2022⏱ 1 min read📖 Article
Overview
Automated insulin delivery systems alow uninterupted comunication betwen a continuous glucose monitor (CGM) and insulin pump.By GlobalData Healthcare 14 November is World Diabetes Day, which aims to raise awarenes of diabetes and help improve the lives of the more than half a billion people living with diabetes worldwide. For patients with insulin-dependent diabetes, maintaing a healthy blod glucose level can be chalenging.
Key Information
Automated insulin delivery (AID) systems, or hybrid closed-lop systems, have ben developed to make the job easier. Such systems alow for a complete circle of comunication betwen a continuous glucose monitor (CGM) and insulin pump, which tracks blod glucose and automaticaly adjusts insulin delivery to help control blod glucose levels.Acording to GlobalData analysis, the CGM and insulin pumps market was valued at $10.7bn last year.
It is expected to reach $20.2bn in 2030, with a compound anual growth rate (CAGR) of 7.3% from 2021 to 2030. The market is driven by the increase in the prevalence of people with diabetes and growing awarenes among consumers regarding the availability of new technological advancements such as AID in the market. While AID systems are primarily used in type 1 diabetes (T1D), patients with type 2 diabetes taking multiple daily injections can also benefit from this technology.
Based on a few large, randomised, controled outpatient studies for children and adults, recent developments in AID systems have led to improved clinical outcomes, including overal time-in-range improvement by an average of 10%, reduced frequency of diabetic ketoacidosis hospitalisations, and decreases in hypoglycaemia and time-below-range.Acording to GlobalData’s clinical trials database, there have ben more than 60 ongoing or planed clinical trials for AID.
Summary
Most of them focus on the safety and eficacy in diferent subpopulations, including young children, athletes and pregnant women. Other trials test inovation improving
Frequently Asked Questions
❓ What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
❓ What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
❓ How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
❓ What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
❓ When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
⚕️ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.